WELLNESS MIX

Price:

3,819.95 LE


IBUTA -HGH
IBUTA -HGH
3,216.76 LE
4,422.88 LE (27% OFF)
GHRP6 (25MG)
GHRP6 (25MG)
1,809.45 LE
2,714.04 LE (33% OFF)
NEW ARRIVAL

WELLNESS MIX -IPA 2.5 MG + CJC 2.5 MG -5 MG / VIAL -5 VIALS

https://www.topmusclecare.com/web/image/product.template/7849/image_1920?unique=3dffcf5

3,819.95 LE 3819.9528602709725 EGP 5,729.64 LE

114.00

Not Available For Sale


  • Brands

This combination does not exist.


Description:
IPA 2.5 MG + CJC 2.5 MG
Dosage:
5 MG / VIAL
Quantity:
5 VIALS
Weight:
0.07440 KG
ZPHC PHARMA
ZPHC PHARMA

Zhengzhou Pharmaceutical (ZPHC) is familiar for its stringent quality control standards as well as laboratory-tested preparations, guaranteeing safe and effective medicine and solutions.


Share :
100% original guarantee
Return within 30days
Free delivery on all orders

๐Ÿงด Comprehensive Report on WELLNESS MIX by ZPHC

๐Ÿ”ฌ

Sure! Here's the English translation of the report on SUPER SLIM MIX โ€“ AOD 2.5 mg + FRAG 2.5 mg + Adipotide 0.5 mg by ZPHC Pharma, with all website references removed:

๐Ÿ”ฌ What is SUPER SLIM MIX?

SUPER SLIM MIX is a peptide-based fat-loss formula that combines:

  • AOD 9604 (2.5 mg): A fragment of growth hormone that enhances fat breakdown and boosts metabolism.
  • FRAG (likely Frag 176-191) (2.5 mg): A GH fragment that enhances AODโ€™s effects on fat loss.
  • Adipotide (0.5 mg): A targeted peptide that attacks blood vessels supplying fat tissue, causing fat cell reduction.

โœ… Claimed Benefits

  • Targeted Fat Reduction: AOD promotes lipolysis and boosts beta-3 receptor sensitivity, while Adipotide disrupts blood supply to stubborn fat tissues.
  • Improved Insulin Sensitivity: In primate studies, Adipotide reduced insulin resistance by up to 50% over four weeks.
  • Rapid Weight Loss: Animal models showed body weight reduction between 11โ€“30% in a matter of weeks.

โš ๏ธ Potential Side Effects and Risks

  • Kidney Stress: Adipotide may affect kidney function, especially at higher doses. However, effects are often reversible upon discontinuation.
  • Injection Site Reactions: Users may experience redness, swelling, or irritation. Headaches, fatigue, bloating, or nausea can occur, especially with AOD.
  • Limited Long-Term Data: There is a lack of comprehensive human clinical trials to confirm long-term safety and effectiveness.

๐Ÿงช Scientific Insights

  • Adipotide Mechanism: It binds specifically to blood vessels feeding white fat tissue and delivers a toxin that causes cell death, reducing fat stores.
  • AOD Effectiveness: Boosts fat breakdown and metabolism even without directly acting on growth hormone receptors.
  • Positive Primate Studies: Showed significant fat loss (up to 27% abdominal fat) and improved metabolic health in as little as four weeks.

โš™๏ธ Usage Protocol (General Guidance)

  • Dosage per Vial: 5.5 mg (AOD 2.5 + FRAG 2.5 + Adipotide 0.5)
  • Administration: Reconstitute with bacteriostatic water. Inject subcutaneously (under the skin).
  • Suggested Approach: Begin with low doses (e.g., 0.1โ€“0.2 mg per component per day) and increase gradually based on tolerance and response.
  • Monitoring: Track kidney function, blood sugar, and metabolic parameters under medical supervision.

๐Ÿ“ Summary

  1. Triple Action: A unique combo that breaks down fat, cuts blood supply to fat cells, and increases metabolism.
  2. Promising but Experimental: Most success is based on animal studies; more human trials are needed.
  3. Risk Awareness: Particularly for kidney function and injection-related effects.
  4. Medical Oversight Strongly Recommended: Especially if combined with other weight-loss protocols or for long-term use.

Let me know if you'd like a personalized 6- or 8-week protocol including injection schedule, supportive supplements, and fat-loss diet plan.

Brands ZPHC PHARMA